TR EN AR RU KK

SNSCSunScout Holding Limited

Technology
🇺🇸 US
0.75
USD
Analysis Scores
Lothien Robustness Score?
45/100
Moderate
Neden bu skor?
Damodaran ?
41/100
Dalio Risk ?
73/100
Piotroski ?
8/9
Strong
Graham ?
$0.1
Pahalı
Active Metric?
4/4
Confidence?
75%
Lothien Robustness Summary
52/100
Lothien Sağlamlık: Orta (52/100)
Karışık sinyaller. Hem olumlu hem olumsuz göstergeler mevcut. | Kısa Vade: Nötr | Uzun Vade: Nötr | Pozitif: 6 | Negatif: 4 | Nötr: 2
Net Kâr Pozitif
Son çeyrekte $196,662 net kâr açıklandı. Şirket kârlı.
Kâr Stabil
Net kâr bir önceki çeyreğe göre fazla değişmedi (%+0.0). İstikrarlı seyir.
Yıllık Kâr Büyümesi Güçlü
Geçen yılın aynı dönemine göre net kâr %+123.9 arttı. Büyüme trendi sağlıklı.
Yıllık Hasılat Büyümesi Güçlü
Yıllık hasılat %+93.6 arttı. Şirket büyüyor.
Yüksek Net Kâr Marjı
Net kâr marjı %16.4. Her 100$ satıştan 16$ kâr kalıyor.
Yüksek Borçluluk
Net borç/özkaynak oranı 2.68x. Yüksek kaldıraç risk taşır, faiz yükü ağır olabilir.
Güçlü Likidite
Cari oran 3.80x — kısa vadeli borçları rahat karşılıyor.
Kârlı ama Nakit Üretemiyor
Net kâr pozitif ($196,662) ama FCF negatif (-$4,003). Yatırım harcamaları yüksek veya alacak birikimi var.
Yüksek F/K Uyarısı
Trailing F/K: 32.7. Piyasa yüksek büyüme bekliyor ya da hisse pahalı. Büyüme gerçekleşmezse düşüş riski yüksek.
Yüksek PD/DD
PD/DD: 19.64. Piyasa defter değerinin çok üstünde fiyatlıyor. Büyüme beklentisi primli.
Yüksek EV/EBITDA
EV/EBITDA: 23.1. Pahalı değerleme.
Sonraki Çeyrek: Artış Beklentisi
Pusla tahminine göre bir sonraki çeyrekte kâr %+29.0 artabilir ($196,662 → $253,756).

Data date 2026-11-10 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Method How the scores are computed · Scorecard
Data date 2026-11-10
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Çok Yüksek
63 days
Annual Volatility ?
%146.9
VaR 95% ?
%16.97
daily max loss
VaR 99% ?
%23.27
daily max loss
CVaR 95% ?
%24.48
expected loss (tail)
Max Drawdown ?
%77.2
12.08.2026 → 30.10.2026
Skewness ?
-1.03
Parametrik%16.97
Historik%14.90
Cornish-Fisher%18.89
Return Distribution
Valuation
Potential?
-32.3%
ROIC ?
26.7%
DCF Value ?
0.05
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/9
Son 3 çeyrek ardışık kâr
Fiyat TRAMA-99 hafif altında: %+0.0
Direnç seviyesi: TRAMA-99 = 0.75 USD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %16.4
Net profit margin %16.4 — at healthy level. Compared to previous quarter +0.0 point increase.
EBITDA Margin %24.6
EBITDA margin %24.6 — good operational performance.
Gross Profit Margin %50.9
Gross profit per revenue %50.9. Strong pricing power.
Free Cash Flow Margin (TTM) %-0.3
TTM Free Cash Flow is %-0.3'i. Negative FCF — company consuming cash.
Valuation
P/E Ratio 32.7x Sector: 25.1x
F/K 32.7x — sector median's (25.1x) %30 above. Slight premium.
P/B Ratio 19.64x Sector: 4.55x
PD/DD 19.64x — sector median's %332 above. Expensive book value.
EV/EBITDA 23.1x Sector: 19.0x
EV/EBITDA 23.1x — sector median's (19.0x) %22 above. Expensive relative to EBITDA.
Indebtedness
Current Ratio 3.01x
Current ratio 3.01x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA 2.1x
Net Debt/EBITDA 2.1x — manageable debt level.
Debt / Equity 1.92x
Debt/Equity 1.92x — high leverage. Sensitive to debt cycle changes.
Interest Coverage 24.7x
Interest coverage 24.7x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY) %+93.6
Revenue YoY %93.6 grew (2025/6) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY) %+123.9
Net profit YoY %123.9 increased (2025/6) — extraordinary profit growth.
Score Explanations
Lothien Robustness
45/100
Moderate robustness (45/100). Valuation and risk criteria give mixed signals. Detailed review recommended.
Moderate
Potential
-32.3%
Minus %32.3 expected value (0.44) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %75.
Components: PE target: 0.54 | P/B target: 0.18 | EV/EBITDA target: 0.53 | DCF target: 0.16
Damodaran Valuation
41/100
Low Damodaran score (41/100). DCF analysis does not support current price.
Weak
Dalio Risk Analysis
73/100
Low debt risk (73/100). Interest coverage ratio 24.7x — strong. Debt/EBITDA 2.1x — manageable.
Leverage: 31/100 | Debt Service: 100/100 | Quality: 98/100
ROIC - Return on Capital
%26.7
ROIC (%26.7) cost of capital 11.1 bps above → company creates value.
WACC: %15.5
DCF Discounted Cash Flow
0.05
DCF (0.05) current price %92.8 below — cash flows do not support current price.
Current price: 0.65
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
8/9
Strong Piotroski F-Score (8/9). Profitability, leverage and operational efficiency criteria are largely met.
Strong
Graham Intrinsic Value
$0.1
Expensive
⚖️ Sector Comparison
P/E Ratio
32.7x vs 25.1x
Sector median's %30 above — expensive
P/B Ratio
19.64x vs 4.55x
Compared to sector %332 more expensive (by book value)
EV/EBITDA
23.1x vs 19.0x
Compared to sector %22 higher EV/EBITDA
ROIC vs WACC
%26.7 vs %15.5 WACC
ROIC 11.1 bps above cost of capital
↔
TRAMA-99 Trend — Near TRAMA
Price (0.75), TRAMA-99 line (0.75) at close levels (%+0.0). Important decision zone — breakout direction will determine the trend.
Price:: 0.75
TRAMA: 0.75
Difference: %+0.0
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
▲ içeriden alım · ▼ içeriden satım · ★ katalizör (haber-sezgisel) · ■ 13D aktivist · ■ 13G pasif — SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
RSI (14) ?
Bollinger Bands ?
MACD ?

İçeriden Alım-Satım Akışı

Kim aldı, kim sattı, ne kadar

SNSC — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.